Sharon Bio-Medicine Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company's revenue from operations was INR 319.405 million compared to INR 404.556 million a year ago. Total income was INR 316.35 million compared to INR 405.522 million a year ago. Net loss was INR 0.338 million or INR 0.00 per basic share compared to profit of INR 6.917 million or INR 0.05 per basic share a year ago. For the nine months, the company's revenue from operations was INR 1,045.189 million compared to INR 936.224 million a year ago. Total income was INR 1,060.792 million compared to INR 937.33 million a year ago. Net profit was INR 75.444 million compared to loss of INR 945.52 million a year ago. Basic earnings per share was INR 0.63 compared to loss per share of INR 7.96 a year ago.